Glycemia and insulin need following FK 506 rescue therapy in liver transplant recipients.
Year: 1991
Type: article
Abstract: During the last decade, newly acquired diabetes mellitus has been reported to follow kidney transplantation in 10% to 46% of the patients.1–5 Although prednisone was thought to be a major factor in azathioprine regimens long before the advent of cyclosporine (CyA),1,4,6 the diabetogenic influence of CyA has received much recent attention.2,3,5,7 Diabetogenic effects also have been ascribed to FK 506, both in animals8,9 and in humans.10–13 In this study, the changes in glucose metabolism were recorded in 72 liver transplant recipients who were changed from CyA to FK 506 therapy because of either uncontrolled rejection or toxicity of the conventional immunosuppressive regimens, or for both reasons.
Source: PubMed
Institution: University of Pittsburgh
Language: English
Subfield: Transplantation
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W84022183
